Group II and Group III antagonists are poorly represented in the literature compared to Group I compounds. An analog from the benzodiazepine chemotype, such as 36, was reported to have very low nanomolar affinity (Ki value of 3 nM) for the mGluR2 receptor and the phenylglycine analog 37 is a representative of a Group III antagonist (64-66).

Was this article helpful?

0 0

Post a comment